Role of virus-receptor interactions in determining norovirus tropism and pathogenesis in vivo
病毒-受体相互作用在确定诺如病毒体内趋向性和发病机制中的作用
基本信息
- 批准号:9791682
- 负责人:
- 金额:$ 18.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-15 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdvisory CommitteesB-LymphocytesBasic ScienceBindingBiochemicalBiological ModelsBiologyBone MarrowCRISPR screenCell Culture SystemCell LineCellsCellular TropismCellular biologyCessation of lifeChronicClinical PathologyCore FacilityCoupledDendritic CellsDepartment chairDiamondDiseaseDisease OutbreaksDisease susceptibilityDoctor of MedicineDoctor of PhilosophyEconomicsEnrollmentEnteralEnvironmentFacultyFosteringGastroenteritisGenesGeneticGenetic Predisposition to DiseaseGenomeGoalsHospitalsHumanIL10 geneImmune systemImmunityImmunodeficient MouseImmunologyInfectionInflammationInflammatory Bowel DiseasesInflammatory disease of the intestineIntegral Membrane ProteinIntegration Host FactorsIntestinesKnockout MiceKnowledgeManuscriptsMedicalMentorsMethodsMolecular BiologyMusNatural ImmunityNorovirusOralPathogenesisPathologyPennsylvaniaPhospholipidsPhysiciansPlayProcessProgram DevelopmentPropertyRecordsResearchResearch InfrastructureResidenciesResourcesRoleRouteScienceScientistShapesSignal TransductionStructural ProteinSusceptibility GeneTestingTimeTrainingTraining ProgramsTropismUniversitiesVaccinesViralViral GastroenteritisViral PathogenesisViral reservoirVirusVirus ReceptorsWashingtonWorkantiviral immunitycareercareer developmentcell typeearly onseteducation resourcesenteric infectionexperienceexperimental studyfollower of religion Jewishgastrointestinalgenome-widehuman modelimmunoregulationin vivoinsightmacrophagemembermouse modelneutrophilnovelpreventprotein structurereceptorresearch facilityreverse geneticsskillstooltransmission processvirome
项目摘要
Project Summary/Abstract
This proposal describes a five-year career development program for the PI, Craig Wilen, M.D., Ph.D. to
with the goal of preparing him for an independent research career as an academic physician-scientist. The PI
graduated summa cum laude from Washington University in St. Louis with a degree in Biology and Economics.
He then enrolled in the Medical Scientist Training Program at the University of Pennsylvania where he earned
his M.D. and Ph.D. in Cell and Molecular Biology. Dr. Wilen continued his training as a resident physician in
the Clinical Pathology Physician Scientist Training Program at Barnes-Jewish Hospital and Washington
University. During his residency elective time, he embarked on basic science research in the lab of Dr. Herbert
Virgin, who will serve as the research mentor in this proposal. Dr. Virgin is the Chair of the Department of
Pathology and Immunology at Washington University and is a highly experienced and productive mentor of
physician-scientists and a leading expert in viral pathogenesis and immunity. Dr. Wilen will continue his
postdoctoral research in this lab.
Washington University provides outstanding faculty members, collaborators, and core research facilities
that will foster Dr. Wilen's scientific progress and career development. First, Dr. Wilen's Career Advisory
Committee comprised of Drs. Diamond, Goldberg, Randolph, and Stappenbeck has extensive scientific
expertise relevant to this proposal and highly successful track records as mentors. Second, the educational
resources including the Office of Postdoctoral Affairs and the Division of Biology and Biomedical Sciences will
enable Dr. Wilen to acquire and develop additional scientific and professional skills. Third, the research
infrastructure within the Virgin lab and Washington University core facilities will enable Dr. Wilen to efficiently
and skillfully address the scientific aims described herein. In summary, Washington University provides the
ideal environment and resources for Dr. Wilen to develop and establish his independent career studying how
viruses interact with the immune system to cause disease.
The long-term goal of this study is to understand the role of virus-receptor interactions in
governing murine norovirus tropism and pathogenesis in vivo. Murine norovirus is an important model for
human norovirus, which is the primary cause of viral gastroenteritis worldwide. In addition, murine norovirus
has been demonstrated to trigger inflammatory bowel disease in mice with certain genetic predispositions.
However, the determinants of murine norovirus tropism and pathogenesis, and the mechanism of virus-
induced enteric inflammation remain unknown. During Dr. Wilen's brief time in the Virgin lab, he performed a
genome-wide CRISPR screen that identified CD300lf as a receptor for murine norovirus. Dr. Wilen is co-first
author on a manuscript currently under review at Science describing this finding. This work has important
implications for human norovirus infection and provides an unprecedented opportunity to study norovirus
biology in vivo. In this proposal we will address the following aims:
Aim1. We will test the hypothesis that CD300lf is necessary and sufficient for MNoV infection ex vivo
and in vivo.
Aim 2. We will test the hypothesis that CD300lf-dependent infection of macrophages, dendritic cells,
and B cells differentially contributes to MNoV pathogenesis in vivo.
These studies will define new mechanisms of murine norovirus pathogenesis, which has important implications
for both human norovirus infection and enteric immunity.
项目摘要/摘要
这份提案描述了一项为期五年的职业发展计划,该计划面向PI、Craig Wilen、M.D.、Ph.D.
目标是为他作为一名学术内科科学家的独立研究生涯做好准备。《少年派》
以优异成绩毕业于圣路易斯华盛顿大学,获得生物学和经济学学位。
然后,他在宾夕法尼亚大学参加了医学科学家培训计划,在那里他获得了
他拥有细胞和分子生物学的医学博士和博士学位。Wilen博士继续他作为住院医生的培训
巴恩斯犹太医院和华盛顿的临床病理医师科学家培训计划
大学。在实习期间,他在赫伯特博士的实验室从事基础科学研究
维珍,他将在这项提案中担任研究导师。维珍博士是
是华盛顿大学病理学和免疫学的一名经验丰富和富有成效的导师
内科科学家,病毒发病机制和免疫方面的领先专家。威伦医生将继续他的
这个实验室的博士后研究。
华盛顿大学提供优秀的教员、合作者和核心研究设施
这将促进Wilen博士的科学进步和职业发展。首先,Wilen博士的职业咨询
由戴蒙德、戈德堡、伦道夫和斯塔彭贝克博士组成的委员会拥有广泛的科学基础
与这项建议相关的专业知识,以及作为导师的非常成功的记录。第二,教育
包括博士后事务办公室和生物和生物医学科学司在内的资源将
使Wilen博士能够获得和发展更多的科学和专业技能。第三,研究
维珍实验室和华盛顿大学核心设施内的基础设施将使Wilen博士能够高效地
并巧妙地解决了这里所描述的科学目标。总而言之,华盛顿大学提供了
为Wilen博士发展和建立他的独立职业生涯提供理想的环境和资源
病毒与免疫系统相互作用导致疾病。
这项研究的长期目标是了解病毒-受体相互作用在
控制小鼠体内诺如病毒的嗜性和致病机制。小鼠诺如病毒是一种重要的
人类诺沃克病毒,这是全世界病毒性胃肠炎的主要原因。此外,小鼠诺如病毒
已被证明在具有某些遗传倾向的小鼠中会引发炎症性肠病。
然而,小鼠诺如病毒嗜性的决定因素和致病机制,以及病毒的致病机制。
诱导性肠炎仍不清楚。在Wilen博士在维珍实验室的短暂时间里,他进行了一次
全基因组CRISPR筛选,鉴定CD300lf为小鼠诺如病毒的受体。Wilen博士是第一位联合
作者在描述这一发现的目前正在接受《科学》杂志审查的手稿上写道。这项工作具有重要的意义
对人类诺沃克病毒感染的影响,为研究诺沃克病毒提供了前所未有的机会
活体生物学。在这项提案中,我们将解决以下目标:
目的:1.我们将验证CD300lf对于MNoV体外感染是必要的和充分的假设
在活体内。
目的2.我们将检验CD300lf依赖的巨噬细胞、树突状细胞、
B细胞在MNoV体内致病机制中起不同作用。
这些研究将确定小鼠诺如病毒致病的新机制,这具有重要的意义
用于人类诺沃克病毒感染和肠道免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig Brian Wilen其他文献
Craig Brian Wilen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig Brian Wilen', 18)}}的其他基金
The role of tuft cells in norovirus pathogenesis
簇细胞在诺如病毒发病机制中的作用
- 批准号:
10435511 - 财政年份:2020
- 资助金额:
$ 18.84万 - 项目类别:
The role of tuft cells in norovirus pathogenesis
簇细胞在诺如病毒发病机制中的作用
- 批准号:
10643944 - 财政年份:2020
- 资助金额:
$ 18.84万 - 项目类别:
The role of tuft cells in norovirus pathogenesis
簇细胞在诺如病毒发病机制中的作用
- 批准号:
10212952 - 财政年份:2020
- 资助金额:
$ 18.84万 - 项目类别:
The role of tuft cells in norovirus pathogenesis
簇细胞在诺如病毒发病机制中的作用
- 批准号:
10052890 - 财政年份:2020
- 资助金额:
$ 18.84万 - 项目类别:
Role of virus-receptor interactions in determining norovirus tropism and pathogenesis in vivo
病毒-受体相互作用在确定诺如病毒体内趋向性和发病机制中的作用
- 批准号:
10059159 - 财政年份:2016
- 资助金额:
$ 18.84万 - 项目类别:
ENGINEERING HIV-RESISTANT HUMAN CD4+ T CELLS
工程设计抗 HIV 人类 CD4 T 细胞
- 批准号:
8358146 - 财政年份:2011
- 资助金额:
$ 18.84万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.84万 - 项目类别:
Research Grant